 Amelia Deitchman, PharmD, PhD
|
| Title | Clinical Pharmacology Fellow |
|---|
| School | UCSF School of Pharmacy |
|---|
| Department | Bioengineering |
|---|
| Address | 1700 4th St
San Francisco CA 94158
|
|---|
| vCard | Download vCard |
|---|
|
|
 Biography | University of Florida, Gainesville, FL | PharmD | 05/2013 | | | University of Florida, Gainesville, FL | PhD | 12/2017 | Pharmaceutical Sciences |
Overview Bibliographic
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
Researchers can login to make corrections and additions, or contact us for help.
-
Deitchman A, Singh RSP, Rand KH, Derendorf H. Enhanced in vitro activity of tigecycline in the presence of chelating agents. Int J Antimicrob Agents. 2018 Jan 03. PMID: 29305959.
-
Singh RSP, Mukker JK, Drescher SK, Deitchman A, Derendorf H. A need to revisit clinical breakpoints of tigecycline: effect of atypical non-linear plasma protein binding. Int J Antimicrob Agents. 2017 Apr; 49(4):449-455. PMID: 28237830.
-
Deitchman A, Heinrichs MT, Khaowroongrueng V, Jadhav SB, Derendorf H. Utility of Microdialysis in Infectious Disease Drug Development and Dose Optimization. AAPS J. 2017 Mar; 19(2):334-342. PMID: 27943149.
-
Deitchman A, de Jong D, Barbour A, Derendorf H. Ceftobiprole medocaril (BAL-5788) for the treatment of complicated skin infections. Expert Rev Anti Infect Ther. 2016 Oct 02. PMID: 27690689.
-
Singh RSP, Mukker JK, Deitchman A, Drescher SK, Derendorf H. Role of Divalent Metal Ions in Atypical Nonlinear Plasma Protein Binding Behavior of Tigecycline. J Pharm Sci. 2016 11; 105(11):3409-3414. PMID: 27616672.
-
Deitchman A, Derendorf H. Measuring drug distribution in the critically ill patient. Adv Drug Deliv Rev. 2014 Nov 20; 77:22-6. PMID: 25194997.
|
Concepts Derived automatically from this person's publications. _
|
